サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：体外診断品質管理の世界市場 (2022～2030年)：成長・将来の展望・競合分析
市場調査レポート
商品コード
1162489

体外診断品質管理の世界市場 (2022～2030年)：成長・将来の展望・競合分析

In-Vitro Diagnostics Quality Control Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日: | 発行: Acute Market Reports | ページ情報: 英文 117 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
体外診断品質管理の世界市場 (2022～2030年)：成長・将来の展望・競合分析
出版日: 2022年08月10日
発行: Acute Market Reports
ページ情報: 英文 117 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の体外診断品質管理の市場規模は、2022年から2030年にかけての予測期間中に3.9％のCAGRで成長すると予測されています。

感染症、心血管障害、腫瘍検査など、さまざまな疾患に対する体外診断検査の利用が拡大しており、同市場の成長を推進しています。また、個別化医療や希少疾患の知識や治療法を探るための分子診断への注力が体外診断薬の使用を後押していることも、同市場を成長させています。

当レポートでは、世界の体外診断品質管理の市場を調査し、市場概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、主要企業のプロファイルなどをまとめています。

目次

第1章 序文

第2章 エグゼクティブサマリー

第3章 体外診断品質管理市場：事業の見通し・市場力学

  • 世界市場の規模：2020年～2030年
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因・抑制要因の影響分析
  • シーソー分析
  • ポーターのファイブフォースモデル
  • PESTEL分析

第4章 体外診断品質管理市場：製品別

  • 市場概要
  • 成長・収益分析
  • 市場の分類
    • 品質管理
    • データ管理ソリューション
    • 品質保証サービス

第5章 体外診断品質管理市場：用途別

  • 市場概要
  • 成長・収益分析
  • 市場の分類
    • 免疫化学
    • 臨床化学
    • 血液
    • 凝固
    • 分子診断
    • 微生物
    • その他

第6章 北米の体外診断品質管理市場

  • 市場概要
  • 体外診断品質管理市場：製品別
  • 体外診断品質管理市場：用途別
  • 体外診断品質管理市場：地域別

第7章 英国およびEUの体外診断品質管理市場

  • 市場概要
  • 体外診断品質管理市場：製品別
  • 体外診断品質管理市場：用途別
  • 体外診断品質管理市場：地域別

第8章 アジア太平洋の体外診断品質管理市場

  • 市場概要
  • 体外診断品質管理市場：製品別
  • 体外診断品質管理市場：用途別
  • 体外診断品質管理市場：地域別

第9章 ラテンアメリカの体外診断品質管理市場

  • 市場概要
  • 体外診断品質管理市場：製品別
  • 体外診断品質管理市場：用途別
  • 体外診断品質管理市場：地域別

第10章 中東・アフリカの体外診断品質管理市場

  • 市場概要
  • 体外診断品質管理市場：製品別
  • 体外診断品質管理市場：用途別
  • 体外診断品質管理市場：地域別

第11章 企業プロファイル

  • Abbott Laboratories Inc.
  • Bio-Rad Laboratories, Inc.
  • Helena Laboratories
  • Ortho Clinical Diagnostics, Inc.
  • Randox Laboratories Ltd.
  • Roche Diagnostics
  • Seracare Life Sciences, Inc.
  • Siemens Healthineers
  • Sun Diagnostics, LLC
  • Thermo Fisher Scientific Inc.
  • Sysmex Corporation
  • Quantimetrix Corporation
図表

List of Tables

  • TABLE 1 Global In-Vitro Diagnostics Quality Control Market By Product, 2020-2030, USD (Million)
  • TABLE 2 Global In-Vitro Diagnostics Quality Control Market By Quality Controls, 2020-2030, USD (Million)
  • TABLE 3 Global In-Vitro Diagnostics Quality Control Market By Application, 2020-2030, USD (Million)
  • TABLE 4 North America In-Vitro Diagnostics Quality Control Market By Product, 2020-2030, USD (Million)
  • TABLE 5 North America In-Vitro Diagnostics Quality Control Market By Quality Controls, 2020-2030, USD (Million)
  • TABLE 6 North America In-Vitro Diagnostics Quality Control Market By Application, 2020-2030, USD (Million)
  • TABLE 7 UK and European Union In-Vitro Diagnostics Quality Control Market By Product, 2020-2030, USD (Million)
  • TABLE 8 UK and European Union In-Vitro Diagnostics Quality Control Market By Quality Controls, 2020-2030, USD (Million)
  • TABLE 9 UK and European Union In-Vitro Diagnostics Quality Control Market By Application, 2020-2030, USD (Million)
  • TABLE 10 Asia Pacific In-Vitro Diagnostics Quality Control Market By Product, 2020-2030, USD (Million)
  • TABLE 11 Asia Pacific In-Vitro Diagnostics Quality Control Market By Quality Controls, 2020-2030, USD (Million)
  • TABLE 12 Asia Pacific In-Vitro Diagnostics Quality Control Market By Application, 2020-2030, USD (Million)
  • TABLE 13 Latin America In-Vitro Diagnostics Quality Control Market By Product, 2020-2030, USD (Million)
  • TABLE 14 Latin America In-Vitro Diagnostics Quality Control Market By Quality Controls, 2020-2030, USD (Million)
  • TABLE 15 Latin America In-Vitro Diagnostics Quality Control Market By Application, 2020-2030, USD (Million)
  • TABLE 16 Middle East and Africa In-Vitro Diagnostics Quality Control Market By Product, 2020-2030, USD (Million)
  • TABLE 17 Middle East and Africa In-Vitro Diagnostics Quality Control Market By Quality Controls, 2020-2030, USD (Million)
  • TABLE 18 Middle East and Africa In-Vitro Diagnostics Quality Control Market By Application, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global In-Vitro Diagnostics Quality Control Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global In-Vitro Diagnostics Quality Control Market: Quality Assurance
  • FIG. 5 Global In-Vitro Diagnostics Quality Control Market, By Product, 2021
  • FIG. 6 Global In-Vitro Diagnostics Quality Control Market, By Application, 2021
  • FIG. 7 Global In-Vitro Diagnostics Quality Control Market, By Geography, 2021
  • FIG. 8 Global In-Vitro Diagnostics Quality Control Market, By Product, 2021 Vs 2030, %
  • FIG. 9 Global In-Vitro Diagnostics Quality Control Market, By Application, 2021 Vs 2030, %
  • FIG. 10 U.S. In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 11 Canada In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 12 Rest of North America In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 13 UK In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 14 Germany In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 15 Spain In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 16 Italy In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 17 France In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 18 Rest of Europe In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 19 China In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 20 Japan In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 21 India In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 22 Australia In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 23 South Korea In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 24 Rest of Asia In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 25 Brazil In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 26 Mexico In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 27 Rest of Latin America In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 28 GCC In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 29 Africa In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
  • FIG. 30 Rest of Middle East and Africa In-Vitro Diagnostics Quality Control Market (US$ Million), 2020 - 2030
目次
Product Code: 138465-08-22

Industry Outlook

The global in-vitro diagnostics quality control market expected to grow at compound annual growth rate (CAGR) of 3.9% during the forecast period from 2022 to 2030. In-vitro diagnostics quality control are tests to validate the efficacy and reliability of the in-vitro diagnostic systems and ensure its accuracy and evaluate the impact of environmental conditions and other things that can affect the test results. Erroneous in-vitro diagnostic testing systems have significant side-effects on the patients. Moreover, it can delay in diagnosis and may also result in improper treatment leading to long-term complications and additional healthcare cost. Moreover, failure to identify the pathogen especially during an outbreak can delay in determining the true cause and thereby lead to inaccurate measures for the same. Poor diagnostic quality also leads to poor patient outcomes, increased mortality and morbidity posing a barrier in public health interventions. Growing usage of in-vitro diagnostic testing for various diseases such as infectious diseases, cardiovascular disorders and oncology testing is the major driver for the growth of in-vitro diagnostics quality control market. Moreover, growing inclination towards personalized medicine and molecular diagnostic to explore knowledge and treatment for rare diseases are boosting use of in-vitro diagnostics, thereby growing the market for in-vitro diagnostics quality control market.

Quality Controls Segment Accounted for the Largest Share by Product Type

The in-vitro diagnostics quality control market is segmented in to quality controls, data management solutions, and quality assurance services. In 2021, quality controls segment held the largest share in the market owing to high demand of these products for validating the accuracy and precision of the in-vitro diagnostic tests. Quality control is an important aspect in the clinical and laboratory based testing to ensure safety and accuracy as per standards set by Food and Drug Administration (FDA), European Communities Confederation of Clinical Chemistry and Laboratory Medicine (EC4) and Clinical Laboratory Improvement Amendments (CLIA).

The key players currently engaged in In-vitro diagnostics quality control market include: Siemens Healthineers, Thermo Fisher Scientific, Inc., Roche Diagnostics, Bio-Rad Laboratories, Inc., Abbott Laboratories, Inc., Seracare Life Sciences, Inc., Sysmex Corporation, Helena Laboratories, Sun Diagnostics, LLC among others.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of In-Vitro Diagnostics Quality Control market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the In-Vitro Diagnostics Quality Control market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

  • Quality Controls
    • Whole Blood-Based Controls
    • Serum/plasma-based Controls
    • Urine-based controls
    • Others
  • Data Management Solutions
  • Quality Assurance Services

Application

  • Immunochemistry
  • Clinical Chemistry
  • Hematology
  • Coagulation
  • Molecular Diagnostics
  • Microbiology
  • Others

Region Segment (2020-2030; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

  • Pre COVID-19 situation
  • Post COVID-19 situation

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of In-Vitro Diagnostics Quality Control market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the In-Vitro Diagnostics Quality Control market?
  • Which is the largest regional market for In-Vitro Diagnostics Quality Control market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving In-Vitro Diagnostics Quality Control market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the In-Vitro Diagnostics Quality Control market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global In-Vitro Diagnostics Quality Control Market
  • 2.2. Global In-Vitro Diagnostics Quality Control Market, By Product, 2021 (US$ Million)
  • 2.3. Global In-Vitro Diagnostics Quality Control Market, By Application, 2021 (US$ Million)
  • 2.4. Global In-Vitro Diagnostics Quality Control Market, By Geography, 2021 (US$ Million)
  • 2.5. Impact of Covid 19
  • 2.6. Attractive Investment Proposition by Geography, 2021
  • 2.7. Competitive Analysis
    • 2.7.1. Market Positioning of Key In-Vitro Diagnostics Quality Control Market Vendors
    • 2.7.2. Strategies Adopted by In-Vitro Diagnostics Quality Control Market Vendors
    • 2.7.3. Key Industry Strategies

3. In-Vitro Diagnostics Quality Control Market: Business Outlook & Market Dynamics

  • 3.1. Introduction
  • 3.2. Global In-Vitro Diagnostics Quality Control Market Value, 2020 - 2030, (US$ Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers
    • 3.3.2. Market Restraints
    • 3.3.3. Key Challenges
    • 3.3.4. Key Opportunities
  • 3.4. Impact Analysis of Drivers and Restraints
  • 3.5. See-Saw Analysis
  • 3.6. Porter's Five Force Model
    • 3.6.1. Supplier Power
    • 3.6.2. Buyer Power
    • 3.6.3. Threat Of Substitutes
    • 3.6.4. Threat Of New Entrants
    • 3.6.5. Competitive Rivalry
  • 3.7. PESTEL Analysis
    • 3.7.1. Political Landscape
    • 3.7.2. Economic Landscape
    • 3.7.3. Technology Landscape
    • 3.7.4. Legal Landscape
    • 3.7.5. Social Landscape

4. In-Vitro Diagnostics Quality Control Market: By Product, 2020-2030, USD (Million)

  • 4.1. Market Overview
  • 4.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 4.3. Market Segmentation
    • 4.3.1. Quality Controls
      • 4.3.1.1. Whole Blood-Based Controls
      • 4.3.1.2. Serum/plasma-based Controls
      • 4.3.1.3. Urine-based controls
      • 4.3.1.4. Others
    • 4.3.2. Data Management Solutions
    • 4.3.3. Quality Assurance Services

5. In-Vitro Diagnostics Quality Control Market: By Application, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Immunochemistry
    • 5.3.2. Clinical Chemistry
    • 5.3.3. Hematology
    • 5.3.4. Coagulation
    • 5.3.5. Molecular Diagnostics
    • 5.3.6. Microbiology
    • 5.3.7. Others

6. North America In-Vitro Diagnostics Quality Control Market, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. In-Vitro Diagnostics Quality Control Market: By Product, 2020-2030, USD (Million)
  • 6.3. In-Vitro Diagnostics Quality Control Market: By Application, 2020-2030, USD (Million)
  • 6.4.In-Vitro Diagnostics Quality Control Market: By Region, 2020-2030, USD (Million)
    • 6.4.1.North America
      • 6.4.1.1. U.S.
      • 6.4.1.2. Canada
      • 6.4.1.3. Rest of North America

7. UK and European Union In-Vitro Diagnostics Quality Control Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. In-Vitro Diagnostics Quality Control Market: By Product, 2020-2030, USD (Million)
  • 7.3. In-Vitro Diagnostics Quality Control Market: By Application, 2020-2030, USD (Million)
  • 7.4.In-Vitro Diagnostics Quality Control Market: By Region, 2020-2030, USD (Million)
    • 7.4.1.UK and European Union
      • 7.4.1.1. UK
      • 7.4.1.2. Germany
      • 7.4.1.3. Spain
      • 7.4.1.4. Italy
      • 7.4.1.5. France
      • 7.4.1.6. Rest of Europe

8. Asia Pacific In-Vitro Diagnostics Quality Control Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. In-Vitro Diagnostics Quality Control Market: By Product, 2020-2030, USD (Million)
  • 8.3. In-Vitro Diagnostics Quality Control Market: By Application, 2020-2030, USD (Million)
  • 8.4.In-Vitro Diagnostics Quality Control Market: By Region, 2020-2030, USD (Million)
    • 8.4.1.Asia Pacific
      • 8.4.1.1. China
      • 8.4.1.2. Japan
      • 8.4.1.3. India
      • 8.4.1.4. Australia
      • 8.4.1.5. South Korea
      • 8.4.1.6. Rest of Asia Pacific

9. Latin America In-Vitro Diagnostics Quality Control Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. In-Vitro Diagnostics Quality Control Market: By Product, 2020-2030, USD (Million)
  • 9.3. In-Vitro Diagnostics Quality Control Market: By Application, 2020-2030, USD (Million)
  • 9.4.In-Vitro Diagnostics Quality Control Market: By Region, 2020-2030, USD (Million)
    • 9.4.1.Latin America
      • 9.4.1.1. Brazil
      • 9.4.1.2. Mexico
      • 9.4.1.3. Rest of Latin America

10. Middle East and Africa In-Vitro Diagnostics Quality Control Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. In-Vitro Diagnostics Quality Control Market: By Product, 2020-2030, USD (Million)
  • 10.3. In-Vitro Diagnostics Quality Control Market: By Application, 2020-2030, USD (Million)
  • 10.4.In-Vitro Diagnostics Quality Control Market: By Region, 2020-2030, USD (Million)
    • 10.4.1.Middle East and Africa
      • 10.4.1.1. GCC
      • 10.4.1.2. Africa
      • 10.4.1.3. Rest of Middle East and Africa

11. Company Profile

  • 11.1. Abbott Laboratories Inc.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Portfolio
    • 11.1.4. Strategic Initiatives
  • 11.2. Bio-Rad Laboratories, Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Portfolio
    • 11.2.4. Strategic Initiatives
  • 11.3. Helena Laboratories
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Portfolio
    • 11.3.4. Strategic Initiatives
  • 11.4. Ortho Clinical Diagnostics, Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Portfolio
    • 11.4.4. Strategic Initiatives
  • 11.5. Randox Laboratories Ltd.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Portfolio
    • 11.5.4. Strategic Initiatives
  • 11.6. Roche Diagnostics
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Portfolio
    • 11.6.4. Strategic Initiatives
  • 11.7. Seracare Life Sciences, Inc.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Portfolio
    • 11.7.4. Strategic Initiatives
  • 11.8. Siemens Healthineers
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Portfolio
    • 11.8.4. Strategic Initiatives
  • 11.9. Sun Diagnostics, LLC
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Portfolio
    • 11.9.4. Strategic Initiatives
  • 11.10. Thermo Fisher Scientific Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Portfolio
    • 11.10.4. Strategic Initiatives
  • 11.11. Sysmex Corporation
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Portfolio
    • 11.11.4. Strategic Initiatives
  • 11.12. Quantimetrix Corporation
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Portfolio
    • 11.12.4. Strategic Initiatives